September 20, 2019
Aerie Pharmaceuticals gets recommendation for Rhokiinsa in the European Union
European Commission will in about two months decide on the Committee for Medicinal Products for Human Use’s positive opinion, recommending approval of Rhokiinsa in EU, developed by Aerie Pharmaceuticals, for reduction of elevated intraocular pressure in adult patients.